At what may be a watershed moment in understanding genetic changes that cause cancer, a small band of doctors is doggedly testing a drug known as PLX4032.
Get the Longreads Weekly Email
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.